-
1
المؤلفون: Drew W. Rasco, Vincent Chung, Mark Voskoboynik, Talia Golan, Mallika Lala, Myung-Ju Ahn, J. Healy, Dai Woo Kim, Elliot Chartash, Corinne Maurice-Dror, Todd M. Bauer, Dongwhane Lee, Adnan Nagrial, Ulka N. Vaishampayan, Jiaxin Niu, Q. Chen, H.C. Chung, K.F. Mileham, Antonio Jimeno
المصدر: Annals of Oncology. 33:169-180
مصطلحات موضوعية: medicine.medical_specialty, Lung Neoplasms, Combination therapy, business.industry, Hematology, Pembrolizumab, Antibodies, Monoclonal, Humanized, medicine.disease, Gastroenterology, Rash, B7-H1 Antigen, Oncology, Tolerability, Pharmacokinetics, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Humans, Hypoalbuminemia, medicine.symptom, Lung cancer, Adverse effect, business, Response Evaluation Criteria in Solid Tumors
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53948764d329f295f8445402dc620fc4
https://doi.org/10.1016/j.annonc.2021.11.002 -
2
المؤلفون: Mallika Lala, Noboru Yamamoto, Lillian L. Siu, Dinesh P. de Alwis, Elliot Chartash, Lokesh Jain, Tommy Ruosi Li, Hesham Aboshady, Kapil Mayawala, Vikram Sinha
المصدر: European Journal of Cancer. 131:68-75
مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Time Factors, Population, Urology, Cmax, Pembrolizumab, Antibodies, Monoclonal, Humanized, Models, Biological, Drug Administration Schedule, 03 medical and health sciences, Cmin, Antineoplastic Agents, Immunological, 0302 clinical medicine, Pharmacokinetics, Neoplasms, medicine, Humans, Computer Simulation, Trough Concentration, Dosing, Infusions, Intravenous, education, Randomized Controlled Trials as Topic, education.field_of_study, Dose-Response Relationship, Drug, business.industry, Middle Aged, Clinical trial, Treatment Outcome, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Female, business
-
3
المؤلفون: Aurélien Marabelle, Emilee Connors, Elliot Chartash, Caroline Gaudy-Marqueste, Antoine Italiano, Konstantin Dobrenkov, Emiliano Calvo Aller, Emanuela Romano, Emiliano Calvo, Martin Wermke, Heng Zhou, Victor Moreno
المصدر: Late-breaking abstracts.
مصطلحات موضوعية: medicine.medical_specialty, Combination therapy, business.industry, Pleural effusion, Anemia, Nausea, Melanoma, Pembrolizumab, medicine.disease, Gastroenterology, Discontinuation, Internal medicine, Medicine, Chills, medicine.symptom, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::121905e0bdf2acdd5ec10ef19de5a237
https://doi.org/10.1136/jitc-2020-sitc2020.0794 -
4
المؤلفون: Jennifer Gwo, Mark Voskoboynik, Kapil Mayawala, Konstantin Dobrenkov, Ravit Geva, Richard Wnek, Georgina V. Long, Elliot Chartash
المصدر: CancerReferences. 126(22)
مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Combination therapy, medicine.medical_treatment, Pembrolizumab, Antibodies, Monoclonal, Humanized, Gastroenterology, Receptors, Tumor Necrosis Factor, 03 medical and health sciences, 0302 clinical medicine, Pharmacokinetics, Renal cell carcinoma, Internal medicine, Neoplasms, medicine, Humans, 030212 general & internal medicine, Adverse effect, business.industry, Immunotherapy, Middle Aged, medicine.disease, Combined Modality Therapy, Oncology, Tolerability, 030220 oncology & carcinogenesis, Pharmacodynamics, Female, business
-
5
المؤلفون: Ferdous Gheyas, Vikram Sinha, Pavan Vaddady, Bernardo Leon Rapoport, Conrad R. Jacobs, Omobolaji Oyekunle Akala, Mallika Lala, Carolina De Miranda Silva, Graham Lawrence Cohen, Elliot Chartash, Lokesh Jain, Dinesh P. de Alwis
المصدر: Cancer Research. 81:CT143-CT143
مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Metastatic melanoma, business.industry, Pembrolizumab, Gastroenterology, Rash, Bioavailability, Oncology, Pharmacokinetics, Internal medicine, Cohort, medicine, medicine.symptom, business, Adverse effect, Advanced melanoma
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::0b5e9493aeb899cb272a8afbb045573e
https://doi.org/10.1158/1538-7445.am2021-ct143 -
6
المؤلفون: Paul Ruff, Karmele Mujika, Sze Wai Chan, Elliot Chartash, Lokesh Jain, Bernardo Leon Rapoport, Conrad R. Jacobs, James R. Anderson, Graham Lawrence Cohen, Ana Arance, Omobolaji Oyekunle Akala, Mallika Lala
المصدر: Journal of Clinical Oncology. 39:9541-9541
مصطلحات موضوعية: Drug, Oncology, Cancer Research, medicine.medical_specialty, business.industry, media_common.quotation_subject, Pembrolizumab, Internal medicine, Cohort, Medicine, business, Advanced melanoma, media_common
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::be6f17490c0eeb9e1964bb2e73968084
https://doi.org/10.1200/jco.2021.39.15_suppl.9541 -
7
المؤلفون: Elliot Chartash, Corinne Maurice-Dror, Adnan Nagrial, Jiaxin Niu, M. Rajasagi, J. Healy, D. Chen, Todd M. Bauer, Mark Voskoboynik, M-J. Ahn, K.F. Mileham, Antonio Jimeno, Vincent Chung, D.H. Lee, H.C. Chung
المصدر: Annals of Oncology. 31:S891-S892
مصطلحات موضوعية: Oncology, medicine.medical_specialty, biology, business.industry, Anti pd 1, Hematology, Pembrolizumab, TIGIT, PD-L1, Internal medicine, biology.protein, medicine, In patient, Antibody, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7c21fa8b571e90bc79e08c4109615603
https://doi.org/10.1016/j.annonc.2020.08.1724 -
8
المؤلفون: Noboru Yamamoto, Lillian L. Siu, Dinesh P. de Alwis, Kapil Mayawala, Mengyao Li, Mallika Lala, Vikram Sinha, Elliot Chartash, Hesham Aboshady, Lokesh Jain, Tommy Ruosi Li
المصدر: European Journal of Cancer. 144:400
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Schedule, business.industry, MEDLINE, Cancer, Pembrolizumab, medicine.disease, Internal medicine, medicine, In patient, Dosing, business
-
9
المؤلفون: D-W. Kim, P. Lo Russo, Jiaxin Niu, Drew W. Rasco, Elliot Chartash, Corinne Maurice-Dror, Ulka N. Vaishampayan, M-J. Ahn, M. Rajasagi, J. Healy, D. Chen, Dongwhane Lee, H.C. Chung, K.F. Mileham, Talia Golan
المصدر: Annals of Oncology. 31:S887
مصطلحات موضوعية: biology, business.industry, Anti pd 1, Hematology, Pembrolizumab, Oncology, TIGIT, Refractory, PD-L1, biology.protein, Cancer research, Medicine, Antibody, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::368ad140b2ced8ca87f5d38435297603
https://doi.org/10.1016/j.annonc.2020.08.1714 -
10
المؤلفون: Elliot Chartash, Lokesh Jain, Dinesh P. de Alwis, Mallika Lala, Shu-Chih Su, Omobolaji Oyekunle Akala, Mizuho Kalabis, Vikram Sinha
المصدر: Cancer Research. 80:CT042-CT042
مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, business.industry, Pembrolizumab, Clinical trial, 03 medical and health sciences, Regimen, 030104 developmental biology, 0302 clinical medicine, Pharmacokinetics, 030220 oncology & carcinogenesis, Internal medicine, Cohort, medicine, Every Three Weeks, media_common.cataloged_instance, Dosing, European union, business, media_common
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::1d8ef5ccc60934dcfca3fe1cc81b3fcf
https://doi.org/10.1158/1538-7445.am2020-ct042